Deep-lung Targeting

Deep-Lung Targeting is a drug delivery strategy that specifically directs inhaled aerosolized therapeutics to the distal regions of the respiratory tract, distinguishing itself by maximizing deposition in the alveolar airspaces while minimizing proximal airway retention.

14

Publications

1.3K

Citations

94

Authors

36

Institutions

Publications per year

2017–2026

4

Authors

94

  1. RV
    Rita Vanbever

    UCLouvain, Belgium

    2 publications · 100 citations

    2

    h-index

  2. BB
    Benoı̂t Baras

    GlaxoSmithKline (Belgium), Belgium

    1 publications · 75 citations

    1

    h-index

  3. JA
    Jacqueline A. French

    New York University, United States

    1 publications · 24 citations

    1

    h-index

  4. AM
    Annette M. Schmidt

    University of Cologne, Germany

    1 publications · 34 citations

    1

    h-index

  5. KR
    Krishnendu Roy

    Georgia Institute of Technology, United States

    1 publications · 67 citations

    1

    h-index

1–5 of 94

Venues

  1. 2

    h-index

  2. Journal of Controlled Release

    2 publications · 92 citations

    2

    h-index

  3. Radiotherapy and Oncology

    1 publications · 257 citations

    1

    h-index

  4. Journal of Visualized Experiments

    1 publications · 20 citations

    1

    h-index

  5. Cell Transplantation

    1 publications · 29 citations

    1

    h-index

1–5